Skip to main content
. 2021 Aug 24;41(11):1941–1947. doi: 10.1007/s00296-021-04975-4

Fig. 3.

Fig. 3

Showing physician treatment choices for remission induction (A), remission maintenance (C), minor (D) and major relapse (E), for development of COVID19 (F) and reasons for choosing remission induction (B for patient with ANCA associated vasculitis (AAV) during COVID-19 pandemic. AZA = Azathioprine; CYC = Cyclophosphamide; IST = Immunosuppressive therapy; IVIG = Intravenous Immunoglobulin; MMF = Mycophenolate Mofetil; MTX = Methotrexate; RTX = Rituximab